Our standardized, fully automated NMR based AXINON® platform allows high-quality metabolomics for study endpoints.
We offer targeted metabolomics for companion diagnostic (CDx) discovery - hepatic/cardiac/renal profiles combined into constellations of relevant metabolites.
Metabolomics is focused on characterization of small molecules which provide a snapshot of physiologic networks and describes the current state of physiological and metabolic processes. NMR based metabolomics is QUANTITATIVE and highly reproducible. numares has developed the fully-automated AXINON® platform allowing for high-quality metabolomics data to be obtained in a robust and reproducible way. numares offers targeted metabolomics - hepatic/cardiac/renal profiles combined into constellations of relevant metabolites for Companion Diagnostics (CDx) discovery.
This targeted metabolomics profiling includes numerous clinically relevant metabolites which are established tests in clinical practice and reported and studied as endpoints in numerous clinical trials. The HEPATIC/CARDIAC/RENAL Profiles provide a snapshot of physiologic networks and describe the current state of physiological and metabolic processes for cardiovascular, renal and liver diseases.
INTEGRATIVE METABOLOMICS – the AXINON® platform with Magnetic Group SignalingTM technology automates signal to data transition for highly accurate and reproducible metabolomics profiling. Coupled with our process for statistical identification of metabolite cohorts and networks, we can provide robust data analysis for association studies.
Learn more about numares targeted metabolomics approach and which metabolites are covered by the Hepatic/Cardiac/Renal profiles:
* For Research Use only in the United States. numares’ technolgy is available for partners within the United States.